BR112014023193A2 - composto da fórmula geral (i): a[l-ch-ca]p e formulação de vacina - Google Patents
composto da fórmula geral (i): a[l-ch-ca]p e formulação de vacinaInfo
- Publication number
- BR112014023193A2 BR112014023193A2 BR112014023193A BR112014023193A BR112014023193A2 BR 112014023193 A2 BR112014023193 A2 BR 112014023193A2 BR 112014023193 A BR112014023193 A BR 112014023193A BR 112014023193 A BR112014023193 A BR 112014023193A BR 112014023193 A2 BR112014023193 A2 BR 112014023193A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- general formula
- vaccine formulation
- vaccine
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2012054848 | 2012-03-19 | ||
| PCT/EP2012/002277 WO2013178236A1 (en) | 2012-05-26 | 2012-05-26 | Carbohydrate-glycolipid conjugate vaccines |
| PCT/EP2013/055719 WO2013139803A1 (en) | 2012-03-19 | 2013-03-19 | Carbohydrate-glycolipid conjugate vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112014023193A2 true BR112014023193A2 (pt) | 2017-08-01 |
Family
ID=47901120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014023193A BR112014023193A2 (pt) | 2012-03-19 | 2013-03-19 | composto da fórmula geral (i): a[l-ch-ca]p e formulação de vacina |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US10588962B2 (pt) |
| EP (1) | EP2827899B1 (pt) |
| JP (2) | JP5933106B2 (pt) |
| KR (1) | KR101675657B1 (pt) |
| CN (1) | CN104321079A (pt) |
| AR (1) | AR090386A1 (pt) |
| AU (1) | AU2013237497B2 (pt) |
| BR (1) | BR112014023193A2 (pt) |
| CA (1) | CA2866978C (pt) |
| CY (1) | CY1116706T1 (pt) |
| DK (1) | DK2827899T3 (pt) |
| ES (1) | ES2551599T3 (pt) |
| HK (1) | HK1205682A1 (pt) |
| HU (1) | HUE028144T2 (pt) |
| IL (1) | IL234604A (pt) |
| MX (1) | MX337202B (pt) |
| PL (1) | PL2827899T3 (pt) |
| PT (1) | PT2827899E (pt) |
| RU (1) | RU2649009C2 (pt) |
| SG (1) | SG11201405646TA (pt) |
| SI (1) | SI2827899T1 (pt) |
| TW (1) | TWI633112B (pt) |
| WO (1) | WO2013139803A1 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2851092A1 (en) | 2013-09-18 | 2015-03-25 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Protein and peptide-free synthetic vaccines against streptococcus pneumoniae type 3 |
| WO2016152980A1 (ja) * | 2015-03-24 | 2016-09-29 | 国立大学法人岐阜大学 | オリゴヌクレオチド誘導体及びそれを用いたオリゴヌクレオチド構築物並びにそれらの製造方法 |
| CN106565800B (zh) * | 2015-10-08 | 2019-08-13 | 中国人民解放军第二军医大学 | 三糖对甲氧基苯酚苷类化合物及其制备方法 |
| TWI732825B (zh) * | 2016-05-20 | 2021-07-11 | 日商王子控股股份有限公司 | 圖案形成用定向自組裝組成物、圖案形成用定向自組裝組成物用單體及圖案形成方法 |
| CN106620682A (zh) * | 2017-01-19 | 2017-05-10 | 华中师范大学 | 一种脂质体疫苗制剂及其用途和生产IgG抗体的方法 |
| MX2020002556A (es) * | 2017-09-07 | 2020-07-13 | Merck Sharp & Dohme | Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora. |
| CN107955082B (zh) * | 2017-12-11 | 2019-05-10 | 江南大学 | 幽门螺旋杆菌脂多糖外核心八糖的制备方法 |
| CN111760020B (zh) * | 2020-05-18 | 2023-05-26 | 广州中医药大学(广州中医药研究院) | 一种缀合物及其制备方法和应用 |
| CN111760021B (zh) * | 2020-05-18 | 2023-06-16 | 广州中医药大学(广州中医药研究院) | 一种含有α-半乳糖神经酰胺类似物与糖抗原的缀合物及其制备方法和应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5936076A (en) | 1991-08-29 | 1999-08-10 | Kirin Beer Kabushiki Kaisha | αgalactosylceramide derivatives |
| FI20010118A (fi) * | 2001-01-19 | 2002-07-20 | Carbion Oy | Uudet helicobacter pylori reseptorit ja niiden käyttö |
| CA2453880A1 (en) * | 2001-07-25 | 2003-02-06 | New York University | Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| US8273357B2 (en) * | 2004-07-16 | 2012-09-25 | Massachusetts Institute Of Technology | Antigen-carbohydrate conjugates |
| WO2006026389A2 (en) | 2004-08-27 | 2006-03-09 | Albert Einstein College Of Medicine Of Yeshiva University | Ceramide derivatives as modulators of immunity and autoimmunity |
| US8022043B2 (en) * | 2004-08-27 | 2011-09-20 | Albert Einstein College Of Medicine Of Yeshiva University | Ceramide derivatives as modulators of immunity and autoimmunity |
| GB0419846D0 (en) * | 2004-09-07 | 2004-10-13 | Chiron Srl | Vaccine adjuvants for saccharides |
| US7923013B2 (en) * | 2004-12-28 | 2011-04-12 | The Rockefeller University | Glycolipids and analogues thereof as antigens for NKT cells |
| WO2007051004A2 (en) * | 2005-10-28 | 2007-05-03 | The Brigham And Women's Hospital, Inc. | Conjugate vaccines for non-proteinaceous antigens |
| US8697659B2 (en) | 2007-10-12 | 2014-04-15 | Luigi Panza | Analogues of glycolipids useful as immunoadjuvants |
| EP2058011A1 (en) * | 2007-11-07 | 2009-05-13 | Wittycell | Nkt cell activating gycolipids covalently bound antigens and/or drug |
| WO2010083728A1 (en) * | 2009-01-23 | 2010-07-29 | Dapeng Zhou | Nanoparticle formulated glycolipid antigens for immunotherapy |
| US8455565B2 (en) | 2011-05-18 | 2013-06-04 | 3M Innovative Properties Company | Disulfide monomers comprising ethylenically unsaturated groups suitable for dental compositions |
-
2013
- 2013-03-19 HU HUE13710422A patent/HUE028144T2/en unknown
- 2013-03-19 MX MX2014011242A patent/MX337202B/es active IP Right Grant
- 2013-03-19 SG SG11201405646TA patent/SG11201405646TA/en unknown
- 2013-03-19 SI SI201330079T patent/SI2827899T1/sl unknown
- 2013-03-19 ES ES13710422.0T patent/ES2551599T3/es active Active
- 2013-03-19 PT PT137104220T patent/PT2827899E/pt unknown
- 2013-03-19 CN CN201380015125.5A patent/CN104321079A/zh active Pending
- 2013-03-19 RU RU2014142043A patent/RU2649009C2/ru active
- 2013-03-19 KR KR1020147029250A patent/KR101675657B1/ko active IP Right Grant
- 2013-03-19 CA CA2866978A patent/CA2866978C/en active Active
- 2013-03-19 TW TW102109653A patent/TWI633112B/zh active
- 2013-03-19 AU AU2013237497A patent/AU2013237497B2/en active Active
- 2013-03-19 US US14/385,948 patent/US10588962B2/en active Active
- 2013-03-19 DK DK13710422.0T patent/DK2827899T3/en active
- 2013-03-19 JP JP2015500890A patent/JP5933106B2/ja active Active
- 2013-03-19 WO PCT/EP2013/055719 patent/WO2013139803A1/en active Application Filing
- 2013-03-19 PL PL13710422T patent/PL2827899T3/pl unknown
- 2013-03-19 EP EP13710422.0A patent/EP2827899B1/en active Active
- 2013-03-19 BR BR112014023193A patent/BR112014023193A2/pt not_active Application Discontinuation
- 2013-03-20 AR ARP130100898A patent/AR090386A1/es unknown
-
2014
- 2014-09-11 IL IL234604A patent/IL234604A/en active IP Right Grant
-
2015
- 2015-06-30 HK HK15106209.7A patent/HK1205682A1/xx unknown
- 2015-09-25 CY CY20151100848T patent/CY1116706T1/el unknown
-
2016
- 2016-04-27 JP JP2016089305A patent/JP6235648B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN104321079A (zh) | 2015-01-28 |
| RU2649009C2 (ru) | 2018-03-29 |
| IL234604A (en) | 2016-03-31 |
| EP2827899B1 (en) | 2015-08-05 |
| EP2827899A1 (en) | 2015-01-28 |
| MX337202B (es) | 2016-02-17 |
| CA2866978C (en) | 2019-01-29 |
| CY1116706T1 (el) | 2017-03-15 |
| PL2827899T3 (pl) | 2015-12-31 |
| KR20140138996A (ko) | 2014-12-04 |
| JP2015514067A (ja) | 2015-05-18 |
| DK2827899T3 (en) | 2015-10-26 |
| SG11201405646TA (en) | 2014-10-30 |
| WO2013139803A1 (en) | 2013-09-26 |
| KR101675657B1 (ko) | 2016-11-11 |
| JP6235648B2 (ja) | 2017-11-22 |
| MX2014011242A (es) | 2015-03-09 |
| TWI633112B (zh) | 2018-08-21 |
| US10588962B2 (en) | 2020-03-17 |
| AU2013237497B2 (en) | 2016-05-12 |
| RU2014142043A (ru) | 2016-05-20 |
| SI2827899T1 (sl) | 2015-11-30 |
| TW201343662A (zh) | 2013-11-01 |
| ES2551599T3 (es) | 2015-11-20 |
| JP2016183166A (ja) | 2016-10-20 |
| HK1205682A1 (en) | 2015-12-24 |
| AR090386A1 (es) | 2014-11-05 |
| PT2827899E (pt) | 2015-11-18 |
| HUE028144T2 (en) | 2016-11-28 |
| AU2013237497A1 (en) | 2014-10-02 |
| CA2866978A1 (en) | 2013-09-26 |
| JP5933106B2 (ja) | 2016-06-08 |
| US20150238597A1 (en) | 2015-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014023193A2 (pt) | composto da fórmula geral (i): a[l-ch-ca]p e formulação de vacina | |
| DK3170508T3 (da) | Vaccineformuleringer | |
| DK2525798T3 (da) | Anæstetisk formulering | |
| BR112015000420A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BR112014029530A2 (pt) | compostos, composição farmacêutica e uso de um composto | |
| DK3335652T3 (da) | Medicinsk fastgørelseselement | |
| BR112015007310A2 (pt) | compostos, composição farmacêutica, uso de um composto de fórmula (i) e uso de uma composição farmacêutica | |
| DK2900645T3 (da) | Herbicidt aktive 3-phenylisoxazolinderivater | |
| GT201200303A (es) | Formulaciones farmacéuticas | |
| BR112014000015A2 (pt) | formulação | |
| CO6940426A2 (es) | Formulaciones farmacéuticas | |
| BR112013009948A2 (pt) | formulação de glifosato | |
| DK2868318T4 (da) | Injicerbar formulering | |
| SMT201700046B (it) | Micobatterio ricombinante come vaccino | |
| BR112013000356A2 (pt) | formulação farmacêutica injetável de malfalano | |
| DK3178474T3 (da) | Farmaceutisk formulering omfattende inositol | |
| CO7010828A2 (es) | Preparación farmacéutica que comprende ßciclodextrina sustituida | |
| CR20130375A (es) | Preparaciones que contienen antraquinona/formulaciones de lignina | |
| HK1205683A1 (en) | Pharmaceutical formulation having improved stability | |
| DK3473255T3 (da) | Farmaceutisk formulering omfattende ciclesonid | |
| BR112015002646A2 (pt) | composto e composição farmacêutica | |
| DK2642980T3 (da) | Pædiatrisk formulering | |
| GB201417069D0 (en) | Use of flagellin as a vaccine | |
| BR112013014291A2 (pt) | formulação lipossômica de calcetrapib | |
| EP2822599A4 (en) | VACCINE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |